In cultured U2OS osteosarcoma cells, loss of SPECC1L results in poor cell migration in wound-repair assays14, increased filamentous actin staining14,18, and at high cell-density, cell-shape change and abnormal staining of adherens junction markers β-catenin and E-cadherin18. Here, SPECC1L is linked to osteosarcoma.